It's the peptide most often stacked with BPC-157 for "recovery" — and one of the most over-promised. Here's what TB-500 actually is, what the science does and doesn't show, and exactly where it stands with the FDA in 2026.
TB-500 is a synthetic peptide fragment related to Thymosin Beta-4 (Tβ4) — a naturally occurring protein found throughout the body that plays a role in cell movement and tissue building. TB-500 itself is a short, lab-made sequence designed to mimic the active region of that larger protein. In the lab and in animal studies it has been investigated mostly for tissue repair: muscle, tendon, ligament, and wound healing. It is not a vitamin, a supplement, or an approved medication.
The honest headline: most of the evidence is preclinical — cell and animal models, often in horses and rodents. Rigorous human clinical trials are very limited, so claims that it "heals" specific injuries in people run well ahead of the data. TB-500 is frequently stacked with BPC-157 in community protocols, but the two being marketed together doesn't make either one proven. That gap between loud marketing and thin human evidence is exactly what this page exists to close.
TB-500 is not an FDA-approved drug. Its status has moved a lot recently, and the nuance matters:
Want the live picture? Our regulatory-status tracker shows exactly where TB-500 and other peptides stand right now, with the dated primary sources.
In animal models, TB-500 and Thymosin Beta-4 have been reported to influence pathways involved in cell migration, blood-vessel formation, and tissue repair, with studies looking at wound healing, cardiac injury, and recovery in horses and rodents. Researchers describe favorable findings in those preclinical settings.
In humans, the picture is far thinner: there are very few controlled clinical trials of TB-500 specifically, and much of what circulates online is anecdote, not data. That doesn't mean it "doesn't work" — it means the evidence needed to say it does, safely, in people, largely isn't there yet. Treat confident before-and-after claims, especially the "BPC + TB-500 stack heals anything" variety, with skepticism.
Commonly reported subcutaneous doses of TB-500 sit around 2–2.5 mg per week, sometimes with a higher initial "loading" phase for the first few weeks before settling into that weekly range. To be clear: these are not approved or standardized doses — they reflect what clinics and the wider community commonly report using today, shared for education, not medical advice. Any decision belongs with a licensed provider.
TB-500 typically ships as a freeze-dried (lyophilized) powder that must be reconstituted with bacteriostatic water before it's a liquid. The math — concentration and the volume to draw — trips a lot of people up, and a misplaced decimal is an easy 1,000× error. That's what our free tool is for:
Human safety data is limited. Commonly reported effects are mild and local (for example, irritation at an injection site), with some users reporting temporary fatigue or head-rush sensations, but long-term safety in humans is simply not well established, and product quality varies enormously between sources. Because much of the supply is research-use-only and unregulated, purity, sterility, and accurate labeling are real concerns — which is why sourcing and testing matter as much as the molecule itself.
If you're considering TB-500, the responsible path runs through a licensed provider who can weigh your situation, not a checkout page. Questions worth asking: Is there third-party testing and a certificate of analysis? What's the source and is it disclosed? What does the provider make of the current legal status while it's under PCAC review? This isn't legal or medical advice — it's the baseline diligence any unapproved substance deserves.
Not exactly. Thymosin Beta-4 is the full natural protein; TB-500 is a synthetic peptide fragment designed to mimic its active region. They're related but not identical, and they're often discussed interchangeably online despite that difference.
It's on the World Anti-Doping Agency (WADA) prohibited list for athletes, and it is not FDA-approved. "Banned" depends on context — competition, prescription, and import rules all differ. Verify for your situation.
They're different peptides often stacked together for recovery. We cover BPC-157 separately in the library; the same caveats about limited human evidence and unapproved status apply to both.
We don't sell peptides and we don't direct consumers to buy unapproved substances. If a licensed provider determines it's appropriate, sourcing and testing should be part of that conversation.
Educational information only. Not medical, legal, or regulatory advice, not a dosing, treatment, or efficacy claim, and not a recommendation to obtain or use any substance. Many peptides are not FDA-approved; some are labeled research-use-only ("not for human use"). Regulatory status changes frequently — verify independently and consult a licensed provider before any health decision. Published by Health Pro Distributors. © 2026.